226 related articles for article (PubMed ID: 31014748)
1. Pathophysiology of hepatic encephalopathy and future treatment options.
González-Regueiro JA; Higuera-de la Tijera MF; Moreno-Alcántar R; Torre A
Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):195-203. PubMed ID: 31014748
[TBL] [Abstract][Full Text] [Related]
2. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
Kristiansen RG
Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
[TBL] [Abstract][Full Text] [Related]
3. Gut ammonia production and its modulation.
Romero-Gómez M; Jover M; Galán JJ; Ruiz A
Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
[TBL] [Abstract][Full Text] [Related]
4. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.
Holecek M
Metab Brain Dis; 2014 Mar; 29(1):9-17. PubMed ID: 23996300
[TBL] [Abstract][Full Text] [Related]
5. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
Rose CF
Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy.
Brusilow SW; Koehler RC; Traystman RJ; Cooper AJ
Neurotherapeutics; 2010 Oct; 7(4):452-70. PubMed ID: 20880508
[TBL] [Abstract][Full Text] [Related]
7. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
Wright G; Noiret L; Olde Damink SW; Jalan R
Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233
[TBL] [Abstract][Full Text] [Related]
8. [Ammonia content and glutamine synthetase and glutaminase activity in the brain in experimental hepatic coma].
Hilgier W
Neuropatol Pol; 1981; 19(3):351-8. PubMed ID: 6119654
[No Abstract] [Full Text] [Related]
9. Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.
Cooper AJ
Metab Brain Dis; 2013 Jun; 28(2):119-25. PubMed ID: 23065027
[TBL] [Abstract][Full Text] [Related]
10. THDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapy.
Díaz-Herrero MM; del Campo JA; Carbonero-Aguilar P; Vega-Pérez JM; Iglesias-Guerra F; Periñán I; Miñano FJ; Bautista J; Romero-Gómez M
PLoS One; 2014; 9(10):e109787. PubMed ID: 25329718
[TBL] [Abstract][Full Text] [Related]
11. Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.
Thomas JW; Banner C; Whitman J; Mullen KD; Freese E
Metab Brain Dis; 1988 Jun; 3(2):81-90. PubMed ID: 2903433
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperammonemia in liver failure.
Jover-Cobos M; Khetan V; Jalan R
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
[TBL] [Abstract][Full Text] [Related]
13. Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.
Romero-Gómez M
Metab Brain Dis; 2005 Dec; 20(4):319-25. PubMed ID: 16382342
[TBL] [Abstract][Full Text] [Related]
14. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
Romero Gómez M; Bautista JD; Grande L; Ramos Guerrero RM; Sánchez Muñoz D
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():40-8. PubMed ID: 15195533
[No Abstract] [Full Text] [Related]
15. Management of hepatic encephalopathy in patients with cirrhosis.
Wright G; Jalan R
Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
[TBL] [Abstract][Full Text] [Related]
16. Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
Soria LR; Nitzahn M; De Angelis A; Khoja S; Attanasio S; Annunziata P; Palmer DJ; Ng P; Lipshutz GS; Brunetti-Pierri N
J Inherit Metab Dis; 2019 Nov; 42(6):1128-1135. PubMed ID: 30724386
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy.
Espíritu-Ramírez P; Ortega-Balderas NY; Sevilla-Tapia L; Montiel-Martínez AG; Pastor-Flores AR; Palomares LA; Torres-Vega MA
Ann Hepatol; 2018 Oct; 17(6):1026-1034. PubMed ID: 30600292
[TBL] [Abstract][Full Text] [Related]
18. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
Tapper EB; Jiang ZG; Patwardhan VR
Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
[TBL] [Abstract][Full Text] [Related]
19. Differential up-regulation of ammonia detoxifying enzymes in cerebral cortex, cerebellum, hippocampus, striatum and liver in hyperammonemia.
Kosenko EA; Tikhonova LA; Reddy VP; Aliev G; Kaminsky YG
CNS Neurol Disord Drug Targets; 2014; 13(6):1089-95. PubMed ID: 25106624
[TBL] [Abstract][Full Text] [Related]
20. Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo.
Kanamori K; Ross BD; Chung JC; Kuo EL
J Neurochem; 1996 Oct; 67(4):1584-94. PubMed ID: 8858943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
